These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 11739008
1. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the OPG/RANKL (osteoprotegerin/receptor activator of NF-kappa B ligand) ratio and serum interleukin-6 in male mice. Lindberg MK, Erlandsson M, Alatalo SL, Windahl S, Andersson G, Halleen JM, Carlsten H, Gustafsson JA, Ohlsson C. J Endocrinol; 2001 Dec; 171(3):425-33. PubMed ID: 11739008 [Abstract] [Full Text] [Related]
2. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB. J Immunol; 2003 Mar 01; 170(5):2655-62. PubMed ID: 12594294 [Abstract] [Full Text] [Related]
3. Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. Swanson C, Lorentzon M, Conaway HH, Lerner UH. Endocrinology; 2006 Jul 01; 147(7):3613-22. PubMed ID: 16614077 [Abstract] [Full Text] [Related]
4. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA. J Bone Miner Res; 2001 Jun 01; 16(6):1004-14. PubMed ID: 11393777 [Abstract] [Full Text] [Related]
10. Two different pathways for the maintenance of trabecular bone in adult male mice. Lindberg MK, Movérare S, Skrtic S, Alatalo S, Halleen J, Mohan S, Gustafsson JA, Ohlsson C. J Bone Miner Res; 2002 Apr 01; 17(4):555-62. PubMed ID: 11918213 [Abstract] [Full Text] [Related]
11. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. Cheung J, Mak YT, Papaioannou S, Evans BA, Fogelman I, Hampson G. J Endocrinol; 2003 Jun 01; 177(3):423-33. PubMed ID: 12773123 [Abstract] [Full Text] [Related]
15. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK. Evans CE, Mylchreest S, Andrew JG. BMC Musculoskelet Disord; 2006 Mar 06; 7():21. PubMed ID: 16519799 [Abstract] [Full Text] [Related]
19. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. Alvarez L, Peris P, Guañabens N, Vidal S, Ros I, Pons F, Filella X, Monegal A, Muñoz-Gomez J, Ballesta AM. Arthritis Rheum; 2003 Mar 06; 48(3):824-8. PubMed ID: 12632438 [Abstract] [Full Text] [Related]
20. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Wada N, Maeda H, Yoshimine Y, Akamine A. Bone; 2004 Sep 06; 35(3):629-35. PubMed ID: 15336598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]